HOME >> MEDICINE >> NEWS
Major grant to IU School of Medicine will expand HIV/AIDS programs in Kenya

INDIANAPOLIS -- The Indiana University School of Medicine has been awarded a $8.9 million federal grant to expand its highly regarded HIV/AIDS programs in Kenya, tripling the number of patients who will be receiving anti-retroviral drug treatments.

The grant, from the President's Emergency Plan for AIDS Relief, is in addition to a $15 million grant for the HIV/AIDS program received by the IU School of Medicine in 2004.

"This funding will save tens of thousands of lives," said Robert Einterz, M.D., associate dean for International Programs in the School of Medicine and director of the IU-Moi program.

The program, known as AMPATH for Academic Model for the Prevention and Treatment of HIV/AIDS, is operated in collaboration with Moi University School of Medicine and Moi Teaching and Referral Hospital. It includes screening programs for pregnant women, efforts to control tuberculosis, and education and training programs for Kenyan medical personnel. AMPATH has opened HIV/AIDS care clinics and screening programs at Moi Teaching and Referral Hospital, eight other hospitals and six rural health centers.

The IU School of Medicine has collaborated with Moi University School of Medicine in Eldoret, Kenya, since Moi's inception in 1990. The IU School of Medicine has supported a team of faculty members and students on-site in Eldoret for the last fifteen years. In addition to enabling IU to contribute to the international effort to reverse the HIV/AIDS epidemic in sub-Saharan Africa, the collaboration strengthens both the Moi University and IU schools of medicine, Dr. Einterz said.

Not only do participating IU students benefit from their experiences treating diseases little seen in the U.S., but the program strengthens the values taught by the IU School of Medicine, Dr. Einterz said.

With the new $8.9 million grant, the AMPATH program will be providing anti-retroviral drug treatments to 18,000 people by September 2007, three
'"/>

Contact: Eric Schoch
eschoch@iupui.edu
317-274-7722
Indiana University
8-Jun-2006


Page: 1 2

Related medicine news :

1. Chinese space agency joins the International Charter Space and Major Disasters
2. Major employers, physicians, stakeholders unite to revolutionize Americas healthcare system
3. Majority of herb users dont follow evidence-based indications, researchers find
4. Majority of state Medicaid programs have or plan to have pay-for-performance programs
5. Major discovery raises prospect of better patient care by improving platelet life span
6. Major visual disorders in people over 40 may be costing the US economy billions
7. Major cancer study aims to identify protein markers for early-stage disease
8. Majority of health care opinion leaders say Medicare Part D helps beneficiaries, changes are needed
9. Major WHO study concludes calcium supplements can reduce complications during pregnancy
10. Major biomarker candidates for Alzheimers disease explored
11. Major ovarian cancer clinical study announced at Yale using combination drug therapy

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Major grant School Medicine will expand HIV AIDS programs Kenya

(Date:8/21/2014)... 2014 The employees of Pharmica ... Washington Crossing, Pennsylvania on Thursday, August 7th to spend ... been looking for different ways that Pharmica could get ... with Pharmica Consulting. “When we heard that we could ... we jumped at the opportunity.” , Pharmica spent their ...
(Date:8/21/2014)... 21, 2014 Sometimes you have to lose the ... new book “From Zero to a Hundred: Finding My Purpose through ... story of surviving a broken family, a childhood of gang violence ... who you were created to be,” Roy said. “I didn’t give ... I know my purpose today of helping others overcome their trials.” ...
(Date:8/21/2014)... Michael E. Steuer , local doctor in ... the Bluff City with recent philanthropy at local synagogue. “The ... United States,” says friend and Rabbi David Julian of Or ... as providing in-house for the needy and teaching Hebrew to ... the local synagogue. And to remain close with the development ...
(Date:8/21/2014)... Drake University’s Phi Gamma Delta (FIJI) and ... cancer research, according to Billy Cundiff, President of Colleen’s ... for the Cleveland Browns, says the money raised by ... Dream Foundation and will fund research to be conducted ... Division of Gynecologic Oncology at the University of Iowa’s ...
(Date:8/21/2014)... Recently, BambooIndustry.com, one of the most famous ... new range of hand scraped bamboo floorings ... an Autumn special offer for these elegant items. According ... a discounted price, up to 25% off; the promotion ... , Providing natural looks and available in different varieties, ...
Breaking Medicine News(10 mins):Health News:Pharmica Spends the Day Helping to Preserve Washington Crossing Historic Park 2Health News:Zero to a Hundred: True Story of Escaping Death to Meet Life 2Health News:Drake University’s Phi Gamma Delta (FIJI) and Colleen’s Dream Foundation Donate $10,000 to the University of Iowa’s Holden Cancer Center to Fight Ovarian Cancer 2Health News:Drake University’s Phi Gamma Delta (FIJI) and Colleen’s Dream Foundation Donate $10,000 to the University of Iowa’s Holden Cancer Center to Fight Ovarian Cancer 3Health News:Cheap Hand Scraped Bamboo Floorings Recently Unveiled by BambooIndustry.com 2
(Date:8/20/2014)... , Aug. 20, 2014 ApolloDx™ today announced ... platform during a special event at the company,s office ... on September 5, 2014. The event, which will start ... ApolloDx website, www.apollodx.com .    "We ... said Jared Bauer , Co-Founder and Managing Partner ...
(Date:8/20/2014)... DIEGO , Aug. 20, 2014 Trovagene, ... diagnostics, announced today that results from two clinical studies ... conference for the Company,s urine-based diagnostic test for the ... The IPV conference is scheduled to take place in ... to 25 th . Additionally, a new U.S. ...
(Date:8/20/2014)... Phase I Trial of Plasma ... KalVista Pharmaceuticals ("KalVista"), an ophthalmology company with a ... it has begun a Phase I, First in Human, ... the treatment of DME. The study,s Principal Investigator is ... Joslin Diabetes Center; Harvard Medical School Department of Ophthalmology, ...
Breaking Medicine Technology:Trovagene Provides Update on Its Urine-Based HPV Test 2Trovagene Provides Update on Its Urine-Based HPV Test 3KalVista Pharmaceuticals Announces Start of Clinical Development for Novel Treatment for Diabetic Macular Edema 2KalVista Pharmaceuticals Announces Start of Clinical Development for Novel Treatment for Diabetic Macular Edema 3KalVista Pharmaceuticals Announces Start of Clinical Development for Novel Treatment for Diabetic Macular Edema 4
Cached News: